Management tracks: Cabaletta, Sage, MyoKardia

Autoimmune cell therapy company Cabaletta Bio Inc. (Radnor, Pa.) hired Anup Marda as CFO. He was VP and head of global corporate financial planning and analysis at Bristol-Myers Squibb Co. (NYSE:BMY). Marda succeeds interim CFO Dan Geffken.

CNS disorders company Sage Therapeutics Inc. (NASDAQ:SAGE) appointed Elizabeth Barrett and George Golumbeski to its board. Barrett became president and CEO of UroGen Pharma Ltd. (NASDAQ:URGN) this month after departing Novartis AG (NYSE:NVS; SIX:NOVN) as CEO of oncology. Golumbeski is president of cancer detection company Grail Inc. (Menlo Park, Calif.)...